Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Evotec SE
  6. News
  7. Sector news
    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 01/21 03:59:32 pm
35.65 EUR   -4.68%
01/20EVOTEC : Upgraded to Buy by Berenberg
MD
01/18EVOTEC : partner Celmatix achieves milestone for PCOS drug programme
PU
01/18EVOTEC : RBC remains its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Biotechnology & Medical Research
04:17pModerna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
12:21pUBS Initiates Coverage on Moderna With Neutral Rating, $221 Price Target
MT
09:29aBofA Securities Upgrades Moderna to Neutral From Underperform, Adjusts Price Target to ..
MT
01/20Moderna says aims to name 'country of choice' for COVID vaccine production in Africa so..
RE
01/20EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid..
RE
01/19Prior COVID infection more protective than vaccination during Delta surge, U.S. study f..
RE
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18Lonza Signs Biologics Development Deal With Forbion, BioGeneration Ventures
MT
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18Seagen Inc. Announces Data from Phase I Clinical Trial Combining SEA-CD40
CI
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Seagen Price Target to $178 From $181, Maintains Equalweight Rat..
MT
01/18Morgan Stanley Adjusts Moderna Price Target to $315 From $313, Maintains Equal Weight R..
MT
01/18Equities Slump Midday After Treasury Yields Touch Two-Year High, Goldman's Earnings Mis..
MT
01/18MIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18EU regulator says mRNA COVID-19 shots do not complicate pregnancies
RE
01/17Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
RE
01/17Moderna To Start Clinical Development Of Vaccine Targeting Omicron Variant
MT
01/17Moderna CEO says data for Omicron-specific shot likely available in March
RE
01/14INSIDER SELL : Moderna
MT
01/14Pieris Doses First Patient in Phase 2 Gastric Cancer Trial of Cinrebafusp Alfa
MT
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/13Moderna Expects to Report Vaccine Data for Young Children in March
DJ
01/12Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March
RE
01/12ICON Reiterates 2021 Guidance, Issues Upside 2022 Earnings Outlook
MT
01/12ICON Public Limited Company Reaffirms Earnings Guidance for the Year 2021
CI
01/11S.Korea authorizes Novavax COVID-19 vaccine, imports Pfizer pills
RE
01/11S.Korea authorises use of Novavax COVID-19 vaccine
RE
01/11Indonesia rolls out booster shots, amid fears of Omicron spread
RE
01/11Wall Street closes higher after Powell testimony eases investors' concerns
RE
01/11Wall Street bounces as Powell's testimony brings some relief
RE
01/11WHO Encourages Covid-19 Vaccine Manufacturers To Generate, Provide Data On Performance ..
RE
01/10Stocks Start Week Mostly Lower, Nasdaq Erases Losses in Late-Session Recovery
MT
01/10Pfizer CEO says Omicron-targeted vaccine is most likely outcome
RE
01/10Moderna Raises 2022 Sales Forecast, Unveils Plan for Omicron-Containing Booster Vaccine..
MT
01/10Equities Slump Midday With Technology Selloff
MT
01/10MIDDAY REPORT : US Stocks Slump With Technology Sell-Off Continuing as Treasury Yields Tou..
MT
01/10Moderna Shares Up After Product Sales Outlook
DJ
01/10Moderna Boosts 2022 Sales Forecast, 2021 Sales Expected To Reach $17.5 Billion
MT
01/10Moderna CEO Says Co Expects To Invest $2.5 Billion To $3 Billion In R&D This Year
RE
01/10Moderna Raises 2022 Product Sales Forecast
MT
01/10Moderna improves forecast for 2022 sales from COVID-19 vaccine
RE
01/10Pfizer CEO says Omicron-targeted vaccine is most likely outcome
RE
01/10Moderna Forms Oncology Collaboration With Carisma Therapeutics
DJ
01/10Moderna Agrees Strategic Collaboration With Carisma Therapeutics for Cancer Treatment
MT
01/10INSIDER SELL : Moderna
MT
01/10Moderna, Inc. and Carisma Therapeutics Inc. Announces Collaboration to Develop in Vivo ..
CI
01/10EU Agency To Meet With Vaccine Makers On Omicron Shot Trials; Approval Expected For Pfi..
MT
01/10Singapore Logs Lowest COVID-19 Deaths Among Individuals Jabbed With Moderna Vaccine
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on EVOTEC SE